SG11201810109UA - Treatment of alphavirus-induced inflammation - Google Patents
Treatment of alphavirus-induced inflammationInfo
- Publication number
- SG11201810109UA SG11201810109UA SG11201810109UA SG11201810109UA SG11201810109UA SG 11201810109U A SG11201810109U A SG 11201810109UA SG 11201810109U A SG11201810109U A SG 11201810109UA SG 11201810109U A SG11201810109U A SG 11201810109UA SG 11201810109U A SG11201810109U A SG 11201810109UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- alphavirus
- queensland
- pct
- inflammation
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title abstract 4
- 230000004054 inflammatory process Effects 0.000 title abstract 4
- 241000710929 Alphavirus Species 0.000 title 1
- 102220240796 rs553605556 Human genes 0.000 abstract 3
- 208000007887 Alphavirus Infections Diseases 0.000 abstract 2
- 229940043138 pentosan polysulfate Drugs 0.000 abstract 2
- 241000710946 Barmah Forest virus Species 0.000 abstract 1
- 206010007710 Cartilage injury Diseases 0.000 abstract 1
- 241001502567 Chikungunya virus Species 0.000 abstract 1
- 206010066919 Epidemic polyarthritis Diseases 0.000 abstract 1
- 102100030931 Ladinin-1 Human genes 0.000 abstract 1
- 101710177601 Ladinin-1 Proteins 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 235000007164 Oryza sativa Nutrition 0.000 abstract 1
- 241000710942 Ross River virus Species 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 235000009566 rice Nutrition 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/AU2016/050408 WO2017201563A1 (fr) | 2016-05-26 | 2016-05-26 | Traitement d'une inflammation induite par un alphavirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201810109UA true SG11201810109UA (en) | 2018-12-28 |
Family
ID=60410929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201810109UA SG11201810109UA (en) | 2016-05-26 | 2016-05-26 | Treatment of alphavirus-induced inflammation |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20190255097A1 (fr) |
| KR (2) | KR20190011761A (fr) |
| AU (2) | AU2016407635B2 (fr) |
| BR (1) | BR112018074235A2 (fr) |
| CA (1) | CA3025018C (fr) |
| MX (1) | MX2018014499A (fr) |
| MY (1) | MY190852A (fr) |
| PH (1) | PH12018502477A1 (fr) |
| SG (1) | SG11201810109UA (fr) |
| WO (1) | WO2017201563A1 (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5145841A (en) | 1987-03-19 | 1992-09-08 | Arthropharm Pty. Limited | Anti-inflammatory compounds and compositions |
| AU1052492A (en) * | 1991-01-31 | 1992-08-06 | Farmitalia Carlo Erba S.R.L. | Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent |
| US5872880A (en) * | 1996-08-12 | 1999-02-16 | Ronald S. Maynard | Hybrid-optical multi-axis beam steering apparatus |
| US20030181416A1 (en) * | 2002-01-10 | 2003-09-25 | Comper Wayne D. | Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof |
| WO2012027797A1 (fr) * | 2010-09-02 | 2012-03-08 | David Charles James | Composition anti-inflammatoire |
| US9902765B2 (en) * | 2013-07-19 | 2018-02-27 | Integral Molecular, Inc. | Antibodies against chikungunya virus and uses thereof |
-
2016
- 2016-05-26 AU AU2016407635A patent/AU2016407635B2/en active Active
- 2016-05-26 KR KR1020187037193A patent/KR20190011761A/ko active Application Filing
- 2016-05-26 MY MYPI2018002104A patent/MY190852A/en unknown
- 2016-05-26 MX MX2018014499A patent/MX2018014499A/es unknown
- 2016-05-26 WO PCT/AU2016/050408 patent/WO2017201563A1/fr active Application Filing
- 2016-05-26 BR BR112018074235-0A patent/BR112018074235A2/pt not_active Application Discontinuation
- 2016-05-26 CA CA3025018A patent/CA3025018C/fr active Active
- 2016-05-26 KR KR1020247013992A patent/KR20240056805A/ko active Application Filing
- 2016-05-26 SG SG11201810109UA patent/SG11201810109UA/en unknown
- 2016-05-26 US US16/304,550 patent/US20190255097A1/en not_active Abandoned
-
2018
- 2018-11-23 PH PH12018502477A patent/PH12018502477A1/en unknown
-
2019
- 2019-05-27 AU AU2019203683A patent/AU2019203683A1/en not_active Abandoned
-
2020
- 2020-05-27 US US16/884,628 patent/US11638718B2/en active Active
-
2023
- 2023-04-04 US US18/130,475 patent/US20230364128A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3025018A1 (fr) | 2017-11-30 |
| AU2016407635A1 (en) | 2018-11-22 |
| US20230364128A1 (en) | 2023-11-16 |
| US20210023124A1 (en) | 2021-01-28 |
| WO2017201563A1 (fr) | 2017-11-30 |
| MX2018014499A (es) | 2019-05-23 |
| US20190255097A1 (en) | 2019-08-22 |
| AU2019203683A1 (en) | 2019-06-20 |
| AU2016407635B2 (en) | 2019-03-07 |
| US11638718B2 (en) | 2023-05-02 |
| MY190852A (en) | 2022-05-12 |
| BR112018074235A2 (pt) | 2019-03-06 |
| CA3025018C (fr) | 2023-08-29 |
| KR20190011761A (ko) | 2019-02-07 |
| KR20240056805A (ko) | 2024-04-30 |
| PH12018502477A1 (en) | 2019-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201907034PA (en) | Methods of treating influenza | |
| SG11201903697WA (en) | Liver organoid compositions and methods of making and using same | |
| SG11201807913XA (en) | Stabilized soluble pre-fusion rsv f proteins | |
| SG11201810423XA (en) | Pd-1 / pd-l1 inhibitors for cancer treatment | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201806863WA (en) | Tetracyclic pyridone compounds as antivirals | |
| SG11201900653RA (en) | Silyl-bridged bis-biphenyl-phenoxy catalysts for olefin polymerization | |
| SG11201907650RA (en) | Personal therapy and exercise monitoring and oversight devices, systems, and related methods | |
| SG11201909960UA (en) | Methods for improving memory and cognition and for treating memory and cognitive disorders | |
| SG11201811225RA (en) | Ar+ breast cancer treatment methods | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201909680UA (en) | Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds | |
| SG11201810454YA (en) | Use of an anti-pd-1 antibody in combination with an anti-cd30 antibody in lymphoma treatment | |
| SG11201810078PA (en) | Stabilized pre-fusion rsv f proteins | |
| SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201407812SA (en) | Methods for reducing levels of protein-contaminant complexes and aggregates in protein preparations by treatment with electropositive organic additives | |
| SG11201903061YA (en) | Combination treatments comprising administration of imidazopyrazinones | |
| SG11201901048VA (en) | Pharmaceutical compositions and uses directed to lysosomal storage disorders | |
| SG11201407536UA (en) | Topical pharmaceutical compositions comprising terbinafine and urea | |
| SG11201810786RA (en) | [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation | |
| SG11201809882XA (en) | Pharmaceutical combinations for treating cancer | |
| SG11201811209QA (en) | Oral gastroretentive formulations and uses thereof | |
| SG11201907951QA (en) | Treatment for gingivitis | |
| SG11201811655SA (en) | Trpa1 antagonists for treatment of dry eye, ocular pain and inflammation |